DOCS
Doximity, Inc.
$21.80
-0.49 (-2.20%)
At close · Jul 14
Market Cap
$3.99B
Shares
182,872,047
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$644.86M
+13.1%
FY2026
Net Income
$196.05M
-12.2%
FY2026
Gross Margin
89.09%
-1.1pp
FY2026
Operating Margin
33.33%
-6.6pp
FY2026
Diluted EPS
$0.98
-11.7%
FY2026
Operating Cash Flow
$326.46M
+19.5%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2027 (G) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|---|
| $664M – $676M | $644.86M | $570.4M | $475.42M | $419.05M | $343.55M | $206.9M | $116.39M | |
| — | $70.33M | $55.87M | $50.67M | $53.49M | $39.79M | $31.2M | $14.9M | |
| — | $574.54M | $514.53M | $424.75M | $365.56M | $303.76M | $175.7M | $101.49M | |
| — | 89.09% | 90.2% | 89.34% | 87.24% | 88.42% | 84.92% | 87.2% | |
| — | $130.7M | $93.04M | $81.98M | $80.19M | $62.35M | $43.87M | $32.44M | |
| — | $163.65M | $145.71M | $133.13M | $123.52M | $92.13M | $62.03M | $39.45M | |
| — | $65.27M | $45.67M | $37.83M | $36.75M | $35.75M | $16.49M | $7.44M | |
| — | $6.5M | $4.3M | $4.6M | $4.8M | $1M | $1.1M | $0 | |
| — | $14.38M | $10.66M | $10.27M | $10.28M | $5.04M | $3.7M | $900K | |
| — | — | $2.3M | $7.94M | $0 | $0 | — | — | |
| — | $359.62M | $286.73M | $260.88M | $240.45M | $190.23M | $122.4M | $79.33M | |
| — | $214.92M | $227.8M | $163.88M | $125.11M | $113.54M | $53.3M | $22.16M | |
| — | 33.33% | 39.94% | 34.47% | 29.86% | 33.05% | 25.76% | 19.04% | |
| — | $229.3M | $238.46M | $174.14M | $135.39M | $118.58M | $57.01M | $23.06M | |
| — | $35.09M | $35.77M | $21.32M | -$146K | -$448K | $4.47M | $1.35M | |
| — | $188K | $169K | -$402K | -$1.09M | -$1.23M | $0 | — | |
| — | $250.01M | $263.57M | $185.2M | $133.16M | $114.01M | $57.77M | $23.51M | |
| — | $53.95M | $40.39M | $37.62M | $20.34M | -$40.78M | $7.56M | -$6.22M | |
| — | $196.05M | $223.19M | $147.58M | $112.82M | $154.78M | $50.21M | $29.74M | |
| — | 30.4% | 39.13% | 31.04% | 26.92% | 45.05% | 24.27% | 25.55% | |
| — | — | — | $147.58M | $112.82M | $133.26M | $21.56M | $10.83M | |
| — | $194.76M | $227.17M | $159M | $114.03M | $139.51M | $50.19M | $29.74M | |
| USD/shares | — | $1.05 | $1.19 | $0.78 | $0.58 | $0.82 | $0.29 | $0.16 |
| USD/shares | — | $0.98 | $1.11 | $0.72 | $0.53 | $0.70 | $0.23 | $0.13 |
| shares | — | 187.01M | 186.84M | 190.17M | 193.18M | 163.48M | 74.34M | 66.76M |
| shares | — | 199.05M | 201.21M | 205.73M | 213.43M | 191.02M | 95.13M | 81.71M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2020–FY2026: $922.71M in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Health Information Services median 1.34×
EV/EBIT
—
Health Information Services median 25.06×
P/E (TTM)
22.24×
Health Information Services median 33.12×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 |
|---|---|---|---|---|---|---|---|
| Subscription | $608,413,000 | $543,770,000 | $450,071,000 | $389,739,000 | $319,298,000 | $192,256,000 | $116,388,000 |
| Service Other | $36,450,000 | $26,629,000 | $25,351,000 | $29,313,000 | $24,250,000 | $14,641,000 | $0 |
Key facts
CIK
1516513
CUSIP
26622P107
13F (30d)
30 filings
27 filers
Visit website
Investor relations